Background: Oncological pain is one of the most prevalent and difficult-to-treat symptoms in
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Introduction
Pain is one of the most common symptoms present in oncologic patients, classified by the World Health Organization (WHO) as a world medical emergency (Gaertner and Schiessl, 2013) , due to its high occurrence, complex physiopathology and difficulty of treatment (Gupta et al., 2018) . In spite of the existence of several drugs for the treatment of pain, there is many a negative aspect as well, once many of them produce frequent dose-related adverse effects. They often prevent the achievement of the suitable doses necessary for adequate analgesia (Eisenberg and Suzan, 2014) , leading to a poor adherence of pharmacotherapy and decreasing quality of life (Ling et al., 2012) .
Therefore, natural products derived from plants stand out as a valuable source of therapeutic agents, once they present a number of bioactive chemical compounds associated to the lower risk of side effects, what makes these products possible candidates for the development of new therapies for chronic pain, such as cancer pain (Bahmani et al., 2014) . In light of this, monoterpenes and sesquiterpenes represent the major composition of essential oils of aromatic herbs, having several pharmacological properties, particularly the analgesic potential (Gomathi and Manian, 2015; Guimarães et al., 2012 Guimarães et al., , 2014b .
p-Cymene (4-isopropyltoluen; PC) is a monoterpene commonly found in several species of herbs, present in the essential oils of over 100 plant species and naturally occurring in more than 200 kinds of food (orange juice, grapefruit, tangerine, butter, carrots, oregano and most of the spices) (Selvaraj et al., 2002) . All over the world, several biological activities have been studied and demonstrated, such as the anti-inflammatory, antinociceptive and analgesic (Bonjardim et al., 2012; de Santana et al., 2015; Quintans-Júnior et al., 2013) and antioxidant activities (de Oliveira , 2015) , as well as the immunomodulatory effect (Zhong et al., 2013) . Those are a few examples among other studies.
Based on the aforementioned, this study aimed to evaluate the effect of the PC in the therapy of nociception induced by Sarcoma 180 in experimental animals and the mechanisms of action involved, as an alternative for the pain associated with cancer.
Material and methods
Drugs and chemicals
The test compounds used in this study were p-cymene (PC) (1-methyl-4-(1-methylethyl) (Zimmermann, 1983) . The animals were
housed randomly in appropriate cages at 21 ± 2 °C on 12 h light/dark cycle and with free access to food (Purina ® , Brazil) and water.
Tumor cell and implantation
Sarcoma 180 (S180) tumor cells were obtained from the Laboratory of Experimental Oncology at the Federal University of Ceará and inoculated in the intraperitoneal region of a maintenance animal. After 10 days of incubation, the mouse was anesthetized, sacrificed and the ascitic fluid was collected from the abdominal cavity. Cells obtained from the ascitic fluid were then analyzed in Neubauer's chamber for the assessment of the percentage of viable cells using Trypan blue solution 1%. A suspension of these tumor cells containing 10 6 cells in 25 μl was implanted in the right hind paw of the mice following a previous protocol (Gouveia et al., 2018; Guimarães et al., 2014a Guimarães et al., , 2015 .
Treatment and behavioral studies
Twenty-four hours after the S180 administrations, the animals (n = 10/group) were treated with vehicle (saline + cremophor 0.4% v/v), PC (12.5, 25 or 50 mg/kg) or morphine (15 mg/kg) via subcutaneous route for 15 consecutive days. During the treatment, behavioral analyses were made on alternating days. The observer responsible for the evaluation was blind to the experimental situation of each animal.
Mechanical hyperalgesia
Mice were evaluated for the sensitivity towards mechanical stimulation by Von Frey's test (electronic anesthesiometer, EFF-301 model, Insight®, Brazil) on the tumor-bearing paw. This stimulation causes a hind limb lifting reflex that corresponds to the paw withdrawal followed by clear movements of flinches (Guimarães et al., 2014a) . The intensity of stimulus was obtained by averaging four measurements performed with minimal intervals of 3 min.
Spontaneous and palpation-induced nociception
The animals were placed in scattered boxes and allowed to acclimate during 10 min and evaluated for spontaneous pain through the observation and quantification of flinches performed during a 10-minute period. Afterwards, non-noxious palpation of the paw containing the tumor was performed for 2 minutes, followed by the quantification of flinches for another 2 minutes.
Both tests were made following protocols previously established (Sabino et al., 2003) .
Movement-evoked pain
The evaluation of the limb use was made through the observation of the animal while walking in a continuous motion in the same boxes scattered, as described by King et al., 2007. This test simulates what occurs among advanced cancer patients, who support body weight on affected limbs. The animals were placed in scattered boxes and allowed to acclimate during 10 min and evaluated for limping and/or guarding behavior of the right (sarcoma-treated) hind limb was rated on the following scale: 0 = complete lack of use, 1 = partial non-use, 2 = limping and guarding, 3 = limping and 4 = normal walking.
Measurement of paw volume
In order to check the effect of PC on tumor growth caused by the S180 implanted in the hind paw of mice, a plethysmometer (Insight ® , Brazil) was used, which measured the dislocation of the water column. The paw volume was obtained by averaging three measurements performed before (time zero) and on every other day up to 15 days.
Measurement of forelimb grip strength
Possible changes in neuromuscular function of the animals were also checked by measuring the tension force of limbs using the commercial grip strength meter (Insight 
Immunohistochemical studies
The animals (n = 6/group) were injected with PC (50 mg/kg; s.c.), morphine ( 
Paw radiography
Animals were sacrificed with the euthanasia method of anesthetic overdose. Thereafter, the right hind paw was removed and fixed in 10% phosphate-buffered formalin for 1 week. After that, the right paws of the animals were radiographed using the Gnatus dental x-ray apparatus, 
Histophatological analysis
Different groups of animals (n = 8/group) were sacrificed by excess sedation on the 15th day after sarcoma inoculation. The paws were then collected, fixed and stained for posterior optical microscopy screening for histopathological characteristics of the tumor, as described by King et al., 2007 .
DRG culture
In order to evaluate the effect of PC on the Ca 2+ current, the dorsal root ganglia cells (DRG) from adult male Wistar rats were used, which were obtained by the dissection protocol adapted from Sleigh et al., 2016 .
Whole-cell voltage-clamp and calcium imaging
The electrophysiological records of DRGs were obtained using the patch-clamp technique in the whole cell under voltage-clamp modality for the measurements of the calcium currents following the established protocol (de Menezes-Filho et al., 2014) .
Docking studies
The intermolecular interactions between PC and the various subtypes of voltage-gated calcium channels (VGCC) were evaluated through docking studies, using as ligands: PC, nicardipine, ω-agatoxin IVA, ω-conotoxin GVIA and N-triazole oxindole (TROX-1). The macromolecules used
were obtained from the Protein Data Bank, which were: CaV1 (L-type) calcium channels (PDB ID 5GJV), CaV2.1 (P/Q-type) calcium channels (PDB ID 3BXK), CaV2.2 (N-type) calcium channels (PDB ID 3DVE) and CaV2.3 (R-type) calcium channels (PDB ID 3BXL). The ligands were subjected to molecular anchoring using molecular docking algorithm MolDock (Thomsen and Christensen, 2006) .
Statistical analysis
The data obtained were evaluated by analyses of variance (ANOVA) in means ± standard error of the mean (SEM) of one-and two-way trials, followed by Tukey's test. For the limb use and paw radiography, the test of Kruskal-Wallis was applied, followed by Dunn's test. In all cases, differences were considered significant if p < 0.05, using the Graph Pad Prism (v 4.00) software (San Diego, CA, USA). The percent of inhibition was determined using the following formula:
Inhibition% (PI) = 100*(control -experiment)/control, with the data obtained from the area under the curve (AUC).
Results and discussion
On the day after the induction of the intraplantar sarcoma 180 tumor cells, the animals began to be evaluated on alternate days until the fifteenth day. The mice did not present an evident hyperalgesic behavior until the ninth day, as a result of the tumor development process, when using von Frey digital analgesimeter. From the eleventh day of observation onward, this difference was statistically significant between the Vehicle and the Sham groups (p < 0.001) ( Fig. 1.A) , demonstrating the hypernociception induced by such model.
The p-cymene (PC) in the dose of 50 mg/kg was capable to revert the hyperalgesic chart from the eleventh to the fifteenth day (p < 0.05) with an average inhibition percentage of 60.4%, such
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12 as morphine (p < 0.01, days 11 to 13; p < 0.001, 15 th day), which also promoted a reduction in the animal sensitization ( Fig. 1.A) . After the fifteenth day, continuing the experiment was impracticable due to tumor development.
In the test of spontaneous nociception, the Sham group showed a significant difference from the vehicle group from the ninth day forward (p < 0.001). All the PC doses maintained the basal behavior of the mice until the thirteenth day (p < 0.001). Furthermore, the 50 mg/kg of PC promoted a significant inhibition percentage of 100% of this behavior, similar to morphine (99.2%) ( Fig. 1.B ).
Evaluating the nociception caused by noxious palpation, all the groups presented a statistical significance when compared to vehicle group (p < 0.001) with inhibition percentages ranging from 75.8% and 72.6% at the lower doses (12.5 and 25 mg/kg, respectively) to 99.2% at the highest dose tested (50 mg/kg) ( Fig. 1.C) .
[INSERT FIG. 1]
Each experiment mimicked a kind of pain presented by patients with neoplasia, as hyperalgesia, spontaneous nociception and allodynia. These have been associated with the sensitization of specific fibers, such as an increase in the suprathreshold response of C and A-δ in hyperalgesia, a sensitization of C-fiber nociceptors in spontaneous nociception and allodynia through a lower threshold of the A-β fibers. The findings herein reported corroborate with the results described by Guimarães et al., 2014a .
Previous studies demonstrated that PC presents a proven anti-inflammatory and analgesic pharmacological profile in models of acute and orofacial pain (Bonjardim et al., 2012 ; de
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pain, such as cancer pain. This study showed that PC was able to attenuate the nociceptive effects against oncological factors.
The effects of PC on tumor development were assessed as for the paw volume, which they were shown not to significantly reduce. The movement-evoked pain test did not show significant inhibition in the reduction of paw utilization by the mice (supplementary material). However, another study demonstrated that PC has the antitumor effect due to the modulation of ERK1/2 and p38 MAPK signal pathways in tumor cells.
It was also assessed that the mice in use of PC showed no difference in the intensity of grip strength when compared to the vehicle group (data not shown), accounting for the absence of any myorelaxant effect provided by the monoterpene under test. In fact, showed that PC was not able to interfere in the motor performance in mice. The tumor component often invaded and dissociated both bundles of skeletal striated muscle fibers and the dermal adipose panicle, at times coming in contact with the bone tissue presenting a few spots of infiltration. Individually, the parenchymal cells exhibited moderated cellular pleomorphism, while the nuclei at times presented dense chromatin and at other times thinly dispersed and one to two prominent nucleoli. Extensive areas of necrosis were also evidenced, as well as interstitial edema, probably due to lymphocytic inflammatory infiltration of variable intensity and some mitotic Fig.s , some of them atypical (Fig. 2.B) .
Regarding the effect of PC on the histopathological characteristics of the tumor, a previously published study has shown that essential oils consisting of PC, such as oregano oil (Origanum vulgare), present high levels of cytotoxicity against animal permanent cell lines, including two derivatives of human cancers (Sivropoulou et al., 1996) . Nonetheless, no significant difference was found between the tumors of the non-treatment group and the group under treatment with PC.
Through radiological and fractal analysis, it was not possible to verify bone lesions associated with the presence of the tumor, demonstrating no evidence that sarcoma 180 is able to invade bone regions within 15 days (supplementary material).
On the fifteenth day, the animals of the vehicle group presented a significant increase (p < 0.001) in the number of positive Fos neurons in the lumbar spinal cord (L4-L6) lamina 1 when compared to the Sham group. PC (50 mg/kg) and morphine (15 mg/kg) groups reduced this neuronal labeling (p < 0.001) (Fig. 3) .
There was also a significant increase in active neurons in the periaqueductal gray (PAG) (Fig.   4A .1) in the animals treated with PC (50 mg/kg) (p < 0.05) and morphine (p < 0.001) as well as in the nucleus raphe magnus (NRM) (p < 0.01 and 0.001, respectively) ( Fig. 4A.2) .
[
INSERT FIG. 4]
The results corroborate a previous study, which showed that some substances with analgesic effect have the capability to increase the expression of Fos protein in regions that comprise the descending pathway of pain, such as PAG and NRM, and consequently decrease this expression in the spinal cord . This pathway is an important site of action of several pharmacological classes related to the analgesic effect, such as opiates, cannabinoids, nonsteroidal anti-inflammatory drugs (NSAIDs) and serotonin/norepinephrine reuptake blockers (Ossipov et al., 2010) .
In fact, previous studies had demonstrated that PC modulates opioid receptors non-selectively (de Santana et al., 2015; Santana et al., 2011) . As it is known, when an opioid agonist binds to a G-protein-coupled opioid receptor, it promotes intracellular alterations, what leads to the activation of potassium conductance and an inhibition of calcium conductance, hyperpolarizing the cell and reducing the pain (Pathan and Williams, 2012) . Although there are already reports about the effect of PC on potassium channels , no study shows its effect on When PC was complexed with the CaV1, CaV2.1, CaV2.2 and CaV2.3 calcium channels, we found negative energy values of -60.118, -59.60, -49.55 and -59.95 kcal/mol, respectively, suggesting that the binding between the targets is favorable and possibly occurs, since the more negative the energy values are, the more favorable the interaction is (Du et al., 2016) . Fig. 6 reports the ligand maps calculated with the best conformations and all the binding energy values in relation to their receptors. Some results were found close to those presented from the control, as it can be seen in the complex of CaV2.2 calcium channels and ω-conotoxin GVIA (binding energy -48.72 kcal/mol). In fact, these VGCCs, mainly CaV2.2, are found in presynaptic
terminals and play an important role in pain neurotransmitter release such as CGRP, substance P, and glutamate (Lee, 2013) .
[ INSERT FIG. 6] Corroborating the above mentioned, PC was able to significantly reduce the calcium current density. The straight inhibition of calcium channels by exogenous substances may possibly induce antinociception by itself (Freitas et al., 2018) . Also, it is one of the action mechanisms of some existing drugs currently used for the treatment of chronic pain, such as gabapentinoids (Catterall and Swanson, 2015) .
Conclusions
Thus, the results of this study clearly demonstrated the antinociceptive effect of PC in the oncological pain model induced by S180, in addition to the properties presented by the drug, such as the neuromodulatory, and its action in calcium current. It is also suggested to act on the ascending and descending pathways of pain inhibition and also to become a possible candidate for the treatment of cancer pain.
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